Investing

Fortrea Holdings : FTRE

FTRE

Stock Data

$18.43

$0.74 (4.18%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Fortrea Holdings Inc. is a key player in the biopharmaceutical and medical device development industry, offering a wide range of services worldwide. With operations in Clinical Services and Enabling Services, the company supports the entire spectrum of clinical development from early-phase trials to post-approval services. Fortrea specializes in streamlining clinical trials through innovative technology solutions, catering to pharmaceutical, biotechnology, and medical device organizations. Based in Durham, North Carolina, Fortrea is known for its comprehensive service models, including full, functional, and hybrid structures, to meet diverse client needs.

Latest Activity

FTREFortrea Holdings Inc.

Q2 2026

Jul 29, 6:36am ET

EPS

$0.23

est $0.18+27.1%

Revenue

$678M

est $648M+4.7%

Clinical research organization Fortrea crushed earnings with a 27% EPS beat and fourth straight quarter of book-to-bill above 1.0x, then raised full-year guidance as cost cuts and commercial traction offset a declining top line.

ShareRead more

All Fortrea Holdings Articles

1 Article

Rich Duprey | Sep 29, 2024 at 11:32 AM EDT

Invest Alongside Wall Street Legend Seth Klarman: 2 New Stocks He Bought and 1 He Dumped

Enigmatic investing legend Seth Klarman runs the Boston-based Baupost Group hedge fund that has around $27 billion in assets under…